FDA Orders Recall and Issues , Warning Over Eyedrops, From CVS, Rite Aid and Others.
'The Independent' reports that health regulators
in the United States have warned consumers
not to use a number of over-the-counter eyedrops.
The Food and Drug Administration issued an advisory
on over two dozen lubricating eyedrops due to a risk
of infections that could result in blindness.
Six companies, including CVS Health and Target, were ordered
to recall the products after FDA inspectors reported
unsanitary conditions and bacteria at production facilities.
Six companies, including CVS Health and Target, were ordered
to recall the products after FDA inspectors reported
unsanitary conditions and bacteria at production facilities.
In an October 27 statement, the FDA warned
consumers to stop using the products and avoid
purchasing any that can still be found in stores. .
'The Independent' reports that the FDA
did not disclose which factory was involved
or when the agency conducted its inspection.
While no infections had been reported at the time of the
FDA's announcement, the agency directed consumers and
doctors to submit cases on its online reporting system. .
While no infections had been reported at the time of the
FDA's announcement, the agency directed consumers and
doctors to submit cases on its online reporting system. .
Earlier in 2023, federal officials connected an outbreak
of a drug-resistant bacteria to eyedrop products produced
by two companies, EzriCare and Delsam Pharma.
According to the Centers for Disease Control and
Prevention, over 80 people have tested positive for
eye-infections caused by this rare strain of bacteria. .
At the time, the companies' products were
recalled after inspectors visited the factory
in India that produced the eyedrops.
Inspectors discovered problems, including
inadequate sterility measures with how the
eyedrops were both produced and tested.